Literature DB >> 12970425

Characterization of the rhesus cytomegalovirus US28 locus.

M E T Penfold1, T L Schmidt, D J Dairaghi, P A Barry, T J Schall.   

Abstract

Human cytomegalovirus (CMV) US28 (and the related open reading frame [ORF] US27) are G-protein-coupled receptor homologs believed to play a role in viral pathogenesis. In vitro, US28 has been shown to bind and internalize ligands, as well as activate intracellular signaling in response to certain chemokines, and to initiate the migration of smooth muscle cells to chemokine gradients. To assess the role of US28 in vivo, we examined the rhesus model and sequenced and characterized the rhesus CMV US28 locus. We found that rhesus CMV carries five tandem homologs of US28, all widely divergent from US28 and from each other. By reverse transcription-PCR and Northern analysis, we demonstrated expression of these ORFs in infected cells. With stable cell lines expressing these ORFs, we analyzed the homolog's binding and signaling characteristics across a wide range of chemokines and found one (RhUS28.5) to have a ligand binding profile similar to that of US28. In addition, we localized US28 and the rhesus CMV homolog RhUS28.5 to the envelope of infectious virions, suggesting a role in viral entry or cell tropism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970425      PMCID: PMC228543          DOI: 10.1128/jvi.77.19.10404-10413.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus.

Authors:  V T De La Melena; C N Kreklywich; D N Streblow; Q Yin; J W Cook; C Soderberg-Naucler; C A Bruggeman; J A Nelson; S L Orloff
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms.

Authors:  S Goda; T Imai; O Yoshie; O Yoneda; H Inoue; Y Nagano; T Okazaki; H Imai; E T Bloom; N Domae; H Umehara
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

3.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).

Authors:  S V Kotenko; S Saccani; L S Izotova; O V Mirochnitchenko; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 4.  Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones.

Authors:  A Gruhler; K Früh
Journal:  Traffic       Date:  2000-04       Impact factor: 6.215

5.  The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling.

Authors:  A Fraile-Ramos; T N Kledal; A Pelchen-Matthews; K Bowers; T W Schwartz; M Marsh
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

6.  Complete DNA sequence of the rat cytomegalovirus genome.

Authors:  C Vink; E Beuken; C A Bruggeman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28.

Authors:  P Casarosa; R A Bakker; D Verzijl; M Navis; H Timmerman; R Leurs; M J Smit
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

Review 8.  A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.

Authors:  M N Prichard; M E Penfold; G M Duke; R R Spaete; G W Kemble
Journal:  Rev Med Virol       Date:  2001 May-Jun       Impact factor: 6.989

Review 9.  Do pathogens accelerate atherosclerosis?

Authors:  D N Streblow; S L Orloff; J A Nelson
Journal:  J Nutr       Date:  2001-10       Impact factor: 4.798

10.  Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.

Authors:  Juliet V Spencer; Kristen M Lockridge; Peter A Barry; Gaofeng Lin; Monica Tsang; Mark E T Penfold; Thomas J Schall
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

View more
  18 in total

1.  Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells.

Authors:  Cynthia A Bolovan-Fritts; Rodney N Trout; Stephen A Spector
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Methods for Studying the Function of Cytomegalovirus GPCRs.

Authors:  Christine M O'Connor; William E Miller
Journal:  Methods Mol Biol       Date:  2021

3.  Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV).

Authors:  Jessica A Scarborough; John R Paul; Juliet V Spencer
Journal:  Infect Genet Evol       Date:  2017-03-14       Impact factor: 3.342

4.  The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2016-08-04       Impact factor: 3.616

Review 5.  Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?

Authors:  Henry F Vischer; Marco Siderius; Rob Leurs; Martine J Smit
Journal:  Nat Rev Drug Discov       Date:  2014-01-21       Impact factor: 84.694

6.  The chemokine receptor homologue encoded by US27 of human cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles.

Authors:  Barry J Margulies; Wade Gibson
Journal:  Virus Res       Date:  2006-09-08       Impact factor: 3.303

7.  The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties.

Authors:  Jeffrey R van Senten; Maarten P Bebelman; Tian Shu Fan; Raimond Heukers; Nick D Bergkamp; Puck van Gasselt; Ellen V Langemeijer; Erik Slinger; Tonny Lagerweij; Afsar Rahbar; Marijke Stigter-van Walsum; David Maussang; Rob Leurs; René J P Musters; Guus A M S van Dongen; Cecilia Söderberg-Nauclér; Thomas Würdinger; Marco Siderius; Martine J Smit
Journal:  J Biol Chem       Date:  2019-09-13       Impact factor: 5.157

8.  Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.

Authors:  Yujuan Yue; Amitinder Kaur; Meghan K Eberhardt; Nadine Kassis; Shan Shan Zhou; Alice F Tarantal; Peter A Barry
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

9.  Patterns of divergence in the vCXCL and vGPCR gene clusters in primate cytomegalovirus genomes.

Authors:  Donald J Alcendor; Jianchao Zong; Aidan Dolan; Derek Gatherer; Andrew J Davison; Gary S Hayward
Journal:  Virology       Date:  2009-10-09       Impact factor: 3.616

Review 10.  Rhesus CMV: an emerging animal model for human CMV.

Authors:  Colin Powers; Klaus Früh
Journal:  Med Microbiol Immunol       Date:  2008-01-11       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.